JNJ-90301900 [Hafnium Oxide] clinical trials

A study of JNJ-90301900 in combination with chemoradiation followed by consolidation immunotherapy for non-small cell lung cancer (NSCLC)

This study is testing a new drug, JNJ-90301900, for a type of advanced lung cancer that can't be removed by surgery. It aims to see if adding this drug, along with standard chemotherapy and radiation, can improve treatment results and is safe for patients.